|
US20030138438A1
(en)
*
|
1998-03-18 |
2003-07-24 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US20030236209A1
(en)
|
1998-03-18 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US6436703B1
(en)
*
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
|
EP1317275A1
(de)
|
2000-09-06 |
2003-06-11 |
Müller, Friederike |
Arzneimittel mit einer für das rna-bindende koc-protein kodierenden dna-sequenz, einem koc-protein oder einer dna-sequenz des koc-promotors
|
|
US7919467B2
(en)
*
|
2000-12-04 |
2011-04-05 |
Immunotope, Inc. |
Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
|
|
EP2113253B1
(en)
|
2008-04-30 |
2010-03-31 |
Immatics Biotechnologies GmbH |
Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines
|
|
US20100037514A1
(en)
|
2008-05-13 |
2010-02-18 |
Afton Chemical Corporation |
Fuel additives to maintain optimum injector performance
|
|
PT2119726E
(pt)
*
|
2008-05-14 |
2015-03-30 |
Immatics Biotechnologies Gmbh |
Novos e poderosos peptídeos para mhc classe ii derivados de survinina e neurocano
|
|
ES2536465T3
(es)
|
2008-10-01 |
2015-05-25 |
Immatics Biotechnologies Gmbh |
Composición de péptidos tumor-asociados y relacionados con la vacuna contra el cáncer para el tratamiento de glioblastoma (GBM) y otros cánceres
|
|
US8253536B2
(en)
|
2009-04-22 |
2012-08-28 |
Simon Fraser University |
Security document with electroactive polymer power source and nano-optical display
|
|
TW201124530A
(en)
*
|
2009-12-01 |
2011-07-16 |
Oncotherapy Science Inc |
IMP-3 oligopeptides and vaccines including the same
|
|
WO2011116126A2
(en)
|
2010-03-16 |
2011-09-22 |
Adapta Medical, Inc. |
Catheter reservoir seals
|
|
GB201004551D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
|
GB201015765D0
(en)
|
2010-09-21 |
2010-10-27 |
Immatics Biotechnologies Gmbh |
Use of myeloid cell biomarkers for the diagnosis of cancer
|
|
CN103201369B
(zh)
|
2010-10-25 |
2016-05-18 |
斯特潘公司 |
基于天然油复分解生成的组合物的衣物洗涤剂
|
|
GB201021289D0
(en)
|
2010-12-15 |
2011-01-26 |
Immatics Biotechnologies Gmbh |
Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer
|
|
US20130295091A1
(en)
|
2011-01-10 |
2013-11-07 |
University Of Zurich |
Combination therapy including tumor associated antigen binding antibodies
|
|
US10279018B2
(en)
|
2012-12-03 |
2019-05-07 |
Unity Biotechnology, Inc. |
Immunogenic compositions for inducing an immune response for elimination of senescent cells
|
|
JP6548579B2
(ja)
|
2012-12-06 |
2019-07-24 |
ヴィクトリア リンク リミテッド |
コンジュゲート化合物
|
|
CA2912389C
(en)
|
2013-06-10 |
2020-01-28 |
The General Hospital Corporation D/B/A Massachusetts General Hospital |
Methods and compositions for reducing immunosupression by tumor cells
|
|
GB201319446D0
(en)
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
|
EA035259B1
(ru)
|
2014-02-14 |
2020-05-21 |
Иммьюн Дизайн Корп. |
Иммунотерапия рака с применением комбинации местной и системной иммунной стимуляции
|
|
JP2017509652A
(ja)
|
2014-03-17 |
2017-04-06 |
ブンデスリパブリク ドイツランド レツバートレテン ダーチ ダス ロバート コシュ−インスティテュト バートレテン ダーチ セイネン プラジデンテン |
細胞性の細胞傷害性免疫応答を誘導または延長する方法における使用のための医薬
|
|
JP2015227292A
(ja)
|
2014-05-30 |
2015-12-17 |
国立大学法人高知大学 |
膵がん細胞浸潤転移抑制ワクチン
|
|
US10046046B2
(en)
|
2014-06-05 |
2018-08-14 |
Victoria Link Limited |
Amino sphingoglycolipid analogues
|
|
GB201504502D0
(en)
|
2015-03-17 |
2015-04-29 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
|
|
GB201505305D0
(en)
*
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
IL301919A
(en)
*
|
2015-03-27 |
2023-06-01 |
Immatics Biotechnologies Gmbh |
Innovative peptides and a combination of peptides for use in immunotherapy against various tumors
|
|
GB201505585D0
(en)
*
|
2015-03-31 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
|
|
GB201507030D0
(en)
*
|
2015-04-24 |
2015-06-10 |
Immatics Biotechnologies Gmbh |
Immunotherapy against lung cancers, in particular NSCLC
|
|
GB201507719D0
(en)
|
2015-05-06 |
2015-06-17 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
|
|
CR20230131A
(es)
*
|
2015-05-06 |
2023-06-23 |
Immatics Biotechnologies Gmbh |
NUEVOS PÉPTIDOS Y NUEVAS COMBINACIONES DE PÉPTIDOS Y DE SOPORTES PARA LA INMUNOTERAPIA CONTRA EL CARCINOMA COLORRECTAL Y OTROS TIPOS DE CÁNCER (Divisional Exp. 2017-0497)
|
|
IL292697A
(en)
*
|
2015-06-19 |
2022-07-01 |
Immatics Biotechnologies Gmbh |
New peptides and their combination for use in immunotherapy and methods for creating supports for use against pancreatic cancer and other types of cancer
|
|
GB201510771D0
(en)
|
2015-06-19 |
2015-08-05 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer
|
|
GB201511546D0
(en)
*
|
2015-07-01 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
IL308735A
(en)
*
|
2015-07-01 |
2024-01-01 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
GB201521746D0
(en)
*
|
2015-12-10 |
2016-01-27 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers
|
|
GB201604494D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Transfected T-Cells and T-Cell receptors for use in immunotherapy against cancers
|
|
GB201604490D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides combination of peptides for use in immunotherapy against cancers
|
|
HRP20221375T1
(hr)
*
|
2016-03-16 |
2023-01-06 |
Immatics Biotechnologies Gmbh |
Transfecirane t-stanice i t-stanični receptori za upotrebu u imunoterapiji protiv raka
|
|
MA43482A1
(fr)
|
2016-04-06 |
2019-05-31 |
Immatics Biotechnologies Gmbh |
Nouveaux peptides et combinaison de peptides pour une utilisation dans l'immunothérapie contre la leucémie myéloïde aiguë (lma) et d'autres cancers
|
|
GB201609193D0
(en)
|
2016-05-25 |
2016-07-06 |
Immatics Biotechnologies Gmbh |
Novel peptides, combination of peptides as targets for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
|
|
TW202304970A
(zh)
|
2016-08-26 |
2023-02-01 |
德商英麥提克生物技術股份有限公司 |
用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架
|
|
JP7722629B2
(ja)
|
2017-07-04 |
2025-08-13 |
キュアバック エスイー |
新規核酸分子
|
|
CN111315769A
(zh)
|
2017-09-06 |
2020-06-19 |
加州理工学院 |
信号传导和抗原呈递双功能受体(sabr)
|
|
US20210382068A1
(en)
|
2018-10-02 |
2021-12-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
|
JP2022096002A
(ja)
|
2019-04-25 |
2022-06-29 |
三洋化成工業株式会社 |
アルカリ電池用ゲル化剤及びアルカリ電池
|
|
AU2020356334A1
(en)
|
2019-09-24 |
2022-03-31 |
Université Catholique de Louvain |
Modified vesicular stomatitis virus glycoprotein and uses thereof for the treatment of brain tumors
|
|
US12394502B2
(en)
|
2019-10-02 |
2025-08-19 |
The General Hospital Corporation |
Method for predicting HLA-binding peptides using protein structural features
|